Pan-cancer analysis revealed mutations or copy number variations of RBM15 in 25 cancer types, with high expression significantly associated with overall survival (OS), disease-free interval (DFI), progression-free interval (PFI), and disease-specific survival (DSS). The gene discussed is RBM15; the disease is cancer.